Retail sale of pharmaceutical products
APOMED HOLDING AS
Revenue 2024
NOK 0
Operating profit
NOK −441,000
Equity
NOK 33.3m
Incorporated
2021
Share capital
NOK 12.3m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 0 | |
| Total operating costs | 441k | |
| Operating profit (EBIT) | −441k | |
| Net financial items | 486k | |
| Profit for the year | 45k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 33.4m | |
| of which current assets | 1.3m | |
| Equity | 33.3m | |
| Total liabilities | 60k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.